Lacprodan MFGM-10 has the most clinical documentation among bovine MFGM ingredients for infant nutrition.

AUSTRALIA – Arla Foods Ingredients’ Milk fat globule membrane (MFGM) has been approved for use in infant formula products in Australia, with Arla Foods Ingredients granted exclusive commercialisation rights.
Lacprodan MFGM-10 will be Arla Foods Ingredients’ first early life nutrition product to be approved by Australian authorities. It will also be the only MFGM ingredient approved for use in products for infants in the country for at least 15 months.
MFGM occurs naturally in human milk and contains phospholipids, sphingolipids, and gangliosides. Lacprodan MFGM-10 was the first bovine MFGM ingredient for the global formula market, and has the most clinical documentation for infant nutrition and immune health.
Jakob Madsen Pedersen, Senior Director, Specialised Nutrition at Arla Foods Ingredients, said: “We’re proud to have pioneered the use of MFGM in infant nutrition, which has allowed significant improvements in the creation of scientifically backed formula products. Following the recent positive decision about Lacprodan MFGM-10 in the EU, this is another highly welcome regulatory development. We’re delighted that its many clinically supported benefits for infants are now also available in Australia.”
On April 30th, 2025, Food Standards Australia New Zealand (FSANZ) approved the use of MFGM as a nutritive substance in infant formula products. Following formal acceptance by the Australia and New Zealand Food Ministers Meeting, the approval is now effective.
It applies across Australia, where Lacprodan MFGM-10 can be labelled as Milk fat globule membrane-enriched whey protein concentrate, but not in New Zealand, which recently opted out of the Australia-New Zealand joint standard for infant formula products.
Arla Foods Ingredients, Alchemy Agencies partner to distribute dairy ingredients
Recently, Arla Foods Ingredients announced a new distribution partnership with Alchemy Agencies to serve the growing nutrition market in Australia, New Zealand and the Pacific Islands.
The distribution agreement will primarily focus on Australia and New Zealand (ANZ), underscoring Arla Foods Ingredients’ strategy to expand sales in Southeast Asia and in ANZ/Oceania, where Alchemy Agencies is a leading distributor of speciality food and beverage ingredients.
Under the new agreement, the following five key brands in Arla Foods Ingredients will be distributed: Nutrilac MFGM, Lacprodan, Capolac, MicelPure, and Nutrilac PB-8420, a high-quality whey and milk protein ingredient that ensures soft texture, processability and robustness for the outer mass of sports protein bars.
Subscribe to receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world. SUBSCRIBE HERE
Be the first to leave a comment